Akero Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Akero Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2024.
  • Akero Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 69.6M shares, a 25% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 69.6M +13.9M +25% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 69.2M +13.7M +24.6% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 69.1M +22.2M +47.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 55.8M +8.89M +19% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 55.7M +9.02M +19.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 55.5M +18M +47.9% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 47M +12M +34.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 46.9M +12M +34.3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 46.7M +11.8M +33.8% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 37.6M +2.73M +7.83% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 35M +253K +0.73% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 34.9M +159K +0.46% Dec 31, 2021 10-K 2023-03-17
Q3 2021 34.9M +155K +0.45% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 34.8M +6.16M +21.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 34.8M +6.1M +21.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 34.7M +6.17M +21.6% Dec 31, 2020 10-K 2022-02-25
Q3 2020 34.7M +6.16M +21.6% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 28.7M +128K +0.45% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 28.7M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 28.6M +28.3M +11854% Dec 31, 2019 10-K 2021-03-16
Q3 2019 28.6M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 28.6M Jun 30, 2019 10-Q 2019-08-12
Q4 2018 239K Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.